Discovering the Shared and Everlasting Future of Humans and Animals : Animals give limitless blessings to the hearts and bodies of us humans. Animal health has direct connections to our health and happiness.  ZENOAQ is trying to seek and find the future possibilities of animal health, and continue to make attempts so that human beings will have more wonderful relationships with animals than are now.

Whats's new and News Release

[ May 27,2016 ] ZENOAQ exhibits at WCVD8 Bordeaux - Booth No.72

ZENOAQ will be exhibiting at WCVD8 Bordeaux in France from May 31 to June 4. Please feel free to drop by Booth No. 72. We look forward to meeting you there.

http://www.vetdermbordeaux.com/

[ May 02,2016 ] Zenoaq and Nexvet Announce PD-1 mAb Candidate for Canine Cancer. USDA Regulatory Jurisdiction Confirmed

Zenoaq and Nexvet Biopharma announced their research and development collaboration has yielded fully caninized, or '100% dog', monoclonal antibodies (mAbs) that bind and potently inhibit the cancer immunotherapy target programmed cell death protein 1 (PD-1).

20160502_press_release_en.pdf

[ December 03,2015 ] Vetoquinol and Nippon Zenyaku Kogyo Co., LTD Sign a Joint - Venture Agreement in Japan

Zenoaq announced that it has signed a Joint - Venture Agreement with Vetoquinol (France) in Japan as of December 3, 2015 to develop, register and market a range of animal health products.

Vetoquinol and Nippon Zenyaku Kogyo Co., LTD Sign a Joint - Venture Agreement in Japan.pdf

[ December 01,2015 ] LAUNCH OF STEM-CELLBANKERⓇ DMSO Free GMP grade

LAUNCH OF STEM-CELLBANKER(R) DMSO Free GMP grade.pdf

[ July 07,2015 ] Zenoaq and Nexvet Enter Research and Development Collaboration

Zenoaq announced that it has signed a Research and Development Agreement with Nexvet Biopharma (Ireland) as of July 1, 2015 to develop a number of therapeutic biologics for companion animals.

Zenoaq and Nexvet Enter Research and Development Collaboration.pdf

Power of ZENOAQ

Creating and combining unique technology and skills to demonstrate corporate power.

ZENOAQ work on Core Competence Management and Management Quality Improvement Program to achieve our corporate philosophy, and we put efforts to create our originality or distinctive competency of research, product, and expansion power.

COMPANY PROFILE

Enhance the brightness of animal and human's future

ZENOAQ have taken control consistently of developing, manufacturing, importing, and selling veterinary pharmaceutical products. There are 41 branch offices in Japan to direct selling system. Manufacturing Plant and Research and Development Facility are compliant with GMP and GLP standards. We are only-one-company possessing Central Research Laboratory and Experimental Farm in Japan.
Also, we have been developing strong relationship with both Japanese and foreign good-standing companies in a positive manner.

PRODUCT

More than 400 kinds of items

Customers are able to choose from many selections as we have more than 400 kinds of product lineup, including in-house product and products from our business partner, for companion animal, production animal and reagent in laboratory use.

CSR

Implementation of CSR activities as a member of society.

ZENOAQ is aiming to not only become a good-standing company in the business field but also a good corporate citizen as an individual. We always feel gratitude to everyone concerned and practice CSR through our activities as a member of society with placing great value on compliance.

ANIMAL IN JAPAN

Animals In Japan is the only website that you are able to get up-to-date information on animal circumstances in Japan in English. ZENOAQ is providing a subject from all topics on animals every month, to whom currently happens, such as animal welfare, environmental issues, food problem, display animal, test animal, service animal, child education, activities of animal-affiliated, and Japanese sense of value etc.